Response to the letter by Robert C. Goodlin, M.D., regarding the use of terbutaline in the treatment of premature labor.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D005260:Female; D006801:Humans; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D011247:Pregnancy; D013726:Terbutaline / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D013726:Terbutaline